WinSanTor

WinSanTor

Growth Stage

Ensuring no one suffers from Peripheral Neuropathy

Ensuring no one suffers from Peripheral Neuropathy

Overview

Raised to Date: Raised: $32,651

Total Commitments ($USD)

Platform

StartEngine

Start Date

03/12/2020

Close Date

04/28/2020

Min. Goal
$10,000
Max. Goal
$535,000
Min. Investment

$500

Security Type

Convertible Note

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$75,000,000

Discount

0%

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

05/02/2020

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$710

# of Investors

30

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2011

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

San Diego, California

WinSanTor, with a valuation cap of $75 million, is raising funds on StartEngine. The company is focused on developing drugs for the treatment of diabetic peripheral neuropathy. The first drug of WinSanTor is in the clinical trial and is expected to reach the patients in the next three years. The class of drugs discovered by WinSanTor scientists increases ATP production in the affected nerves and increases their growth. WinSanTor was founded by Paul Fernyhough, Nigel Calcutt, and Lakshmi Kotra and has already received over $25 million in peer-reviewed grants. The current round of crowdfunding has a minimum goal of $10,000 and a maximum goal of $535,000, and the funds will be used to complete the Phase 2 trials and prepare for the Phase 3 clinical trials. WinSanTor is bringing about a breakthrough in science, and its drugs could be the only disease-modifying treatment for any form of peripheral neuropathy.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
WinSanTor 04/28/2024 Wefunder $500,000,000 $193,502 SAFE Funded RegCF
WinSanTor 04/27/2020 StartEngine $75,000,000 $32,651 Convertible Note Not Funded RegCF
WinSanTor 03/19/2019 Wefunder $70,000,000 $596,649 SAFE Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
WinSanTor Inc. on StartEngine
Platform: StartEngine
Security Type: Convertible Note
Valuation: $75,000,000

Follow company

Follow WinSanTor Inc. on StartEngine

Buy WinSanTor's Deal Report

Warning: according to the close date for this deal, WinSanTor may no longer be accepting investments.

WinSanTor Deal Report

Get KingsCrowd’s comprehensive report on WinSanTor including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether WinSanTor is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the WinSanTor deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge